Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/12/2006US7148054 Evolution of whole cells and organisms by recursive sequence recombination
12/12/2006US7148053 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease
12/12/2006US7148046 Three-dimensional model; drug design
12/12/2006US7148039 Protein derived composition for skin care using spider silk protein or an analog with adjuvants
12/12/2006US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
12/12/2006US7148036 DNA molecules encoding cartilage-derived morphogenetic proteins
12/12/2006US7148035 Polypeptide
12/12/2006US7148030 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis
12/12/2006US7148029 Generating antibodies; quantitative analysis
12/12/2006US7148026 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
12/12/2006US7148022 Assay for anti-viral agent
12/12/2006US7148021 Human zona pellucida proteins and methods of their use in diagnosing male infertility
12/12/2006US7148020 Triple polypeptide complexes
12/12/2006US7148019 Treating grass pollen allergen by administering a genetic engineered or synthetic protein or polypeptide; antiallergens
12/12/2006US7148015 Circovirus sequences associated with piglet weight loss disease (PWD)
12/12/2006US7148014 Methods of inhibiting phagocytosis
12/12/2006US7148013 Complex of Hepatitis B virus polymerase with p11 and method for controlling movement of the complex in HepG2 cell
12/12/2006US7148011 Method of testing for allergic diseases
12/12/2006US7148006 Screenining and detection of antiproliferative agentst; obtain tumor cells, incubate with antiproliferative agents, monitor reduction in tumor activity
12/12/2006US7148005 Nucleic acid-based methods of detecting bacterial o-antigens
12/12/2006US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
12/12/2006US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006US7147861 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
12/12/2006US7147857 Methods for treating high somatic cell counts
12/12/2006US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006US7147853 Nucleotide sequences codin polypeptide for use in the treatment and prevention of cell proliferative and tumor disorders
12/12/2006US7147852 Methods for reducing TGF-β production and for promoting repair of liver damage
12/12/2006US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006US7147839 Methods for evaluating tissue morphogenesis and activity
12/12/2006US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases
12/12/2006CA2253809C Molecular genetic construction of vaccine strains of pasteurellaceae
12/12/2006CA2207723C Method for removing n-terminal methionine
12/12/2006CA2189659C Production of biologically active recombinant neurotrophic protein
12/12/2006CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins
12/12/2006CA2159907C A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
12/12/2006CA2153336C Recombinant virus immunotherapy
12/12/2006CA2129045C Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
12/12/2006CA2105277C Genetically engineered vaccine strain
12/07/2006WO2006130806A2 Assay for agonists and antagonists of ion channels and for regulators of genetic expression
12/07/2006WO2006130745A1 Macromolecular conjugates of bone morphogenetic protein-7
12/07/2006WO2006130503A2 Errϝ peptide fragment complexes and uses thereof in drug discovery
12/07/2006WO2006130135A1 Compositions and methods for the treatment of tumor of hematopoietic origin
12/07/2006WO2006130127A2 The dmi1 gene encodes a protein that is required for the early steps of bacterial and fungal symbiosis
12/07/2006WO2006130082A1 A peptide ligand to impair cancer cell migration
12/07/2006WO2006129867A2 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN
12/07/2006WO2006129849A1 Anti-cd14 antibody-fused protein
12/07/2006WO2006129828A2 Target substance capturing molecule
12/07/2006WO2006129796A1 Support for carrying magnetic particles and method of preparing the same
12/07/2006WO2006129393A1 Composition for treating periodontal disease
12/07/2006WO2006129317A1 BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE (α S ) ANALOGS
12/07/2006WO2006129204A2 Rnai for control of insects and arachnids
12/07/2006WO2006129139A1 N protein mutants of porcine reproductive and respiratory syndrome virus
12/07/2006WO2006129085A2 High affinity melan-a t cell receptors
12/07/2006WO2006128921A2 Means and methods to modulate flavonoid biosynthesis in plants and plant cells
12/07/2006WO2006128908A1 Production of recombinant il-18 binding protein
12/07/2006WO2006128864A2 Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease
12/07/2006WO2006128689A2 Therapeutic composition for use in the prevention and treatment of bone metastases
12/07/2006WO2006128678A1 Molecular glue
12/07/2006WO2006128668A2 Coagulation factor x polypeptides with modified activation properties
12/07/2006WO2006128460A2 Pegylated g-csf polypeptides and methods of producing same
12/07/2006WO2006128388A1 Method for gel electrophoresis separation of serum lipoproteins and quantization dection thereof
12/07/2006WO2006128296A1 Pal-based chlamydia vaccine
12/07/2006WO2006128289A1 Use of brevinin-2r in the treatment of cancer
12/07/2006WO2006111524A3 Il-21 variants
12/07/2006WO2006109301A3 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
12/07/2006WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
12/07/2006WO2006099309A3 Keratin and soluble derivatives thereof for treating oxidative stress and inflammation and promoting skin health
12/07/2006WO2006096515A3 Modified transferrin fusion proteins
12/07/2006WO2006091803A3 Transcriptional regulation of cytokines by litaf and stat6(b)
12/07/2006WO2006090090A3 Hiv epitopes and pharmaceutical composition containing same
12/07/2006WO2006086822A9 A molecule and chimeric molecules thereof
12/07/2006WO2006081418A3 Ephb receptor-binding peptides
12/07/2006WO2006053565A3 Polypeptides having antimicrobial activity and polynucleotides encoding same
12/07/2006WO2006046134A3 Method of screening by using conformation sensitive peptides
12/07/2006WO2006045308A3 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/07/2006WO2006037811A3 Protracted exendin-4 compounds
12/07/2006WO2006033679A3 Self-assembling nanoparticle drug delivery system
12/07/2006WO2006006165A3 Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders
12/07/2006WO2005115448A3 Multi plasmid system for the production of influenza virus
12/07/2006WO2005110464A3 Irx5 inhibition as treatment for hyperproliferative disorders
12/07/2006WO2005108563A3 Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4
12/07/2006WO2005089252B1 Methods and compositions for the treatment of obesity
12/07/2006WO2005044992A3 Fusion initiation region in rna virus envelope proteins
12/07/2006WO2004100861A3 Pharmaceutical composition comprising lectin
12/07/2006WO2004074454A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
12/07/2006WO2004024882A3 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/07/2006WO2004012668A3 Sodium channel alpha subunit variants
12/07/2006WO2004003153A3 Live replicating spumavirus vector
12/07/2006WO2003029401A8 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
12/07/2006WO2003020913A3 Anopheles gambiae odorant receptors and genes
12/07/2006WO2002036732A3 Active variants of fgf with improved specificity
12/07/2006US20060277635 Inducing immunity via oral administration of fusion protein complex comprising (multimeric) cholera toxin and immunogenic antigen
12/07/2006US20060277633 Genes regulating circadian clock function and photoperiodism
12/07/2006US20060277631 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
12/07/2006US20060277630 Generation of plants with altered oil content
12/07/2006US20060277629 Using expression vector comprising nucleotide sequences coding adenlylate transport protein as tool in generating plants with increased tocopherol levels
12/07/2006US20060277625 Determining the species of a plant transposon by determining the transposon nucleotide sequence using an oligonucleotide primer; confirming the presence of the transposon; fractioning the plant DNA segments to obtain a sequence; comparing the sequence with pre-determined plant DNA sequences
12/07/2006US20060277617 Nucleic acid construct, metabolic disordered non-human animal and use thereof
12/07/2006US20060277614 Mammal prolactin variants
12/07/2006US20060277613 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera